Additional studies, such as genetic or proteomic studies, will help us understand its relevance in PD and to establish whether FCGBP may be used as a marker for the early diagnosis and/or prognosis of disease processes specifically for PD. This evidence concerns the gene FCGBP and Parkinson disease.